New Oncology Drugs/Indications Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 347
- Publication type:
- Article
Works matching IS 21641153 AND DT 2021 AND VI 11 AND IP 6
Results: 16
1
2
The Political Raid on Future Cures.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 346
- Publication type:
- Article
3
Biden's Price Controls Will Make Good Health More Expensive.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 345
- By:
- Publication type:
- Article
4
Drug Price Reform with Value in Mind: Can It Happen?
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 343
- Publication type:
- Article
5
Medically Integrated Oncology Pharmacy Promotes Patient-Centric Care.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 342
- Publication type:
- Article
6
The Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 340
- Publication type:
- Article
7
The Impact of Telehealth on Cancer Care.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 339
- Publication type:
- Article
8
Adagrasib Shows Promising Activity in Metastatic Colorectal Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 338
- Publication type:
- Article
9
Study Shows mRNA COVID-19 Vaccine Effective and Safe in Patients with Cancer Undergoing Treatment.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 337
- Publication type:
- Article
10
Abiraterone Added to Androgen-Deprivation Therapy Significantly Improves Metastasis-Free Survival in Patients with High-Risk Prostate Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 336
- Publication type:
- Article
11
Trastuzumab Deruxtecan Tops Trastuzumab Emtansine as Second-Line Therapy in HER2-Positive Metastatic Breast Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 335
- Publication type:
- Article
12
Hypersensitivity Reactions to Taxanes and Subsequent Treatment with Nab-Paclitaxel: Case Reports of 2 Women with Early-Stage Breast Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 329
- By:
- Publication type:
- Article
13
CAR T-Cell Therapy: Review of the Newest Weapon in the Battle Against Hematologic Malignancies.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 318
- By:
- Publication type:
- Article
14
Evaluating Antibiotic Use and Opportunities for Intervention in Patients with Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 312
- By:
- Publication type:
- Article
15
Impact of Using Adjusted Body Surface Area in Obese Patients Receiving Ablative Busulfan plus Fludarabine Conditioning Regimen Before Hematopoietic Stem-Cell Transplant.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 306
- By:
- Publication type:
- Article
16
Dosing Chemotherapy in Obese Patients, Still Not Answered.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 6, p. 304
- By:
- Publication type:
- Article